Saxenda is a medication approved by NICE in the United Kingdom. It is approved for weight loss if the following patient descriptors are present, also known as Eligibility criteria:
1. Patient has a Body Mass Index greater than or equal to 30 Kg/m².
2. Patient has a Body Mass Index greater than or equal to 27 kg/m²
a) 'Prediabetes' or Type 2 Diabetes
b) High Blood Pressure
c) High Cholesterol
d) Obstructive Sleep Apnoea
You need to inject yourself every day - I will demonstrate how to do this in clinic. It sounds difficult but it really isn't. You will have hands on practice before you leave - something other clinics do not do.
Saxenda ®️ works in 4 ways: it makes you feel full for longer by slowing stomach emptying after eating, through feedback mechanisms it tells your brain that you are full (so no 'hangry' feelings), it suppress glucagon secretion (lowering glucose levels) and stimulates insulin secretion from the pancreas in a more physiological fashion in response to high glucose levels in the blood. GLP1a medications are a response to a failure in the body that occurs with Type 2 Diabetes.
The regime of use: In the first week you inject 0.6mg each day at the same time, the second week you up the dose to 1.2mg, week 3 you will up to 1.8mg, week 4 2.4mg and from week 5 onwards will be taking 3.0mg a day for the remainder that you are on the medication.
The medication will make you not want to eat, but you must. This will be explained more in clinic - the best advice is to have small snacks regularly through the day and to eat smaller portions at meal times coupled with drinking plenty of water. This is all explained in the patient information pack and the "real world patient guide".
Contraindications to prescription use of Saxenda Medication, if you have any of these then Saxenda isn't suitable for you, however my colleagues may very well be able to help you:
1. Heart Failure
2. 🔞<18 years old or >75 years old
3. Kidney Disease
4. Liver Disease
5. Pancreatic/Pancreas disease
6. Stomach/Gut Issues
7. Pregnant or Breastfeeding
8. Diabetic on either Insulin or Sulfonylureas (e.g. Gliclazide, Tolbutamide or Glimepiride)
£200. Thats it. Flat fee. No repeat prescription charges
Unlike any other provider of Saxenda in Jersey, I am at my patient's call 7 days a week. Simply use the Contact Us or WhatsApp function on the website.
Every pharmacy on Jersey charges different amounts. At Castle Quay Pharmacy its £50 a pen. What you find is that you reduce your food and alcohol intake. So the cost of the pen is covered in reduction of food/alcohol intake, effectively paying for itself
Depends on the dose, is the simple answer. If you are at the maximum daily dose of 3mg then each pen lasts 6 days.
During the start of treatment: 1st Pen lasts 17 days, 2nd Pen 8 days, 3rd Pen 6 days and so on.
You do not bring the full boxes to the clinic for disposal. There is a designated yellow bin at the Enid Quenault Centre at Quennevais (former Quennevais School site now new outpatients department)
I do not charge repeat fees. This is covered in your initial consultation fee, unlike other individuals/organisations.
Via the website. On the Booking & Repeat Prescription Page. You must include all key data. You must already be a client of B@CastleQuay Weight Loss clinic
I won't continue prescribing. Its important that I see you are hitting weight loss targets and tolerating the medication
It is ultrafine and used by diabetics everyday. Best place to start is the thigh skin. Avoid areas on the tummy where your elastic/clothing waistline contacts the skin.
It does nip initially but you get used to it very quickly.
As you increase the dose, you increase the volume injected and therefore its less pleasant. That being said, you get used to the discomfort rapidly and stop thinking about it.
You can choose to track your weight but only if you feel mentally strong enough and don't obsess. After 2 months you will start to see and feel the difference. Then after 3 months you may then find clothes fit more readily and you will want to exercise and try other lifestyle choices - thats where Philip Blake, Laura Foster and Vic Kelly can help you (see Working With Others page)
Both are names for Semaglutide which is a longer acting GLPa medication that you take weekly. The 'famous' version of this is Ozempic, but is in short supply at present - it also does not have a license for the treatment of weight loss. However the weight loss version is called Wegovy (exactly the same drug but different dosing structure). That was originally intended to be available at the end of May 2023 but NovoNordisk have had issues with supply - as of July 4th 2023 the company representatives that I work with were unable to give me a roll out date. However this will be something I offer in the future.